Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MEDROXYPROGESTERONE Cause Injection site indentation? 17 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Injection site indentation have been filed in association with MEDROXYPROGESTERONE (Provera). This represents 0.2% of all adverse event reports for MEDROXYPROGESTERONE.

17
Reports of Injection site indentation with MEDROXYPROGESTERONE
0.2%
of all MEDROXYPROGESTERONE reports
0
Deaths
1
Hospitalizations

How Dangerous Is Injection site indentation From MEDROXYPROGESTERONE?

Of the 17 reports, 1 (5.9%) required hospitalization.

Is Injection site indentation Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MEDROXYPROGESTERONE. However, 17 reports have been filed with the FAERS database.

What Other Side Effects Does MEDROXYPROGESTERONE Cause?

Meningioma (1,364) Drug dose omission by device (510) Device leakage (500) Incorrect dose administered by device (410) Drug ineffective (403) Off label use (390) Syringe issue (354) Needle issue (346) Headache (288) Device occlusion (284)

What Other Drugs Cause Injection site indentation?

ADALIMUMAB (241) EXENATIDE (224) EVOLOCUMAB (189) ERENUMAB-AOOE (152) GLATIRAMER (149) ALIROCUMAB (73) SEMAGLUTIDE (66) TIRZEPATIDE (55) DUPILUMAB (51) INTERFERON BETA-1A (46)

Which MEDROXYPROGESTERONE Alternatives Have Lower Injection site indentation Risk?

MEDROXYPROGESTERONE vs MEDROXYPROGESTERONE\MEDROXYPROGESTERONE MEDROXYPROGESTERONE vs MEFENAMIC ACID MEDROXYPROGESTERONE vs MEFLOQUINE MEDROXYPROGESTERONE vs MEGESTROL MEDROXYPROGESTERONE vs MEGLUMINE

Related Pages

MEDROXYPROGESTERONE Full Profile All Injection site indentation Reports All Drugs Causing Injection site indentation MEDROXYPROGESTERONE Demographics